Table 1 Patient characteristics
From: Ibuprofen gargle for chemo- or Chemoradiotherapy-induced Oral Mucositis: a feasibility study
No. | Age | Sex | Cancer type | TNM stage | Regimen (CT/CRT) | Onset of oral mucositis (Grade 2–3) | Pain VAS (baseline) |
|---|---|---|---|---|---|---|---|
1 | 58 | M | Hypopharyngeal carcinoma | T3N2cM0 | CDDP+RT | Cycle 2 day 5 | 6.2 |
2 | 73 | F | Lacrimal sac tumor | T4N0M0 | CDDP+RT | Cycle 2 day 12 | 0.1 |
3 | 77 | M | Hypopharyngeal carcinoma | cT4aN2cM0 | TPF | Cycle 1 day 13 | 7.1 |
4 | 64 | F | Gingival cancer | pT4aN0M0 | CDDP+RT | Cycle 2 day 1 | 4.2 |
5 | 75 | M | Primary unknown cancer | TxN3M0 | CDDP+RT | Cycle 3 day 2 | 2.0 |
6 | 83 | M | Oropharyngeal cancer | cT3N2bM0 | CDDP+RT | Cycle 1 day 14 | 4.6 |
7 | 32 | F | Tongue cancer | pT2cN0M0 | CDDP+RT | Cycle 3 day 2 | 3.2 |
8 | 52 | M | Maxillary sinus cancer | T4aN0M0 | CDDP+ETOP +RT | Cycle 4 day 13 | NE |
9 | 25 | F | Oral cavity cancer | pT2N1M0 | CDDP+RT | Cycle 2 day 8 | 2.3 |
10 | 75 | M | Gingival cancer | pT2N2bM0 | CDDP+RT | Cycle 2 day 3 | 3.5 |